Chemours lifted at RBC Capital on TiO2 margin recovery
RBC Capital upgraded shares of Chemours (CC) to Outperform from Sector Perform in a note Friday, raising the price target on the stock to $40 from $28 per share.Analysts said the firm is...
|
|
|
Name
|
Last
|
High
|
Low
|
Chg
|
Chg%
|
Volume
|
Time
|
|---|---|---|---|---|---|---|---|---|---|
| MTN | 10,336 | 10,520 | 10,239 | +42 | +0.41% | 4.55M | |||
| Discovery | 13,182 | 13,470 | 13,103 | -122 | -0.92% | 1.32M | |||
| Shoprite | 25,301 | 25,950 | 25,157 | -414 | -1.61% | 690.86K | |||
| Sasol | 20,680 | 21,096 | 20,173 | -406 | -1.94% | 2.74M | |||
| Sasfin | 2,730 | 2,730 | 2,649 | +81 | +3.06% | 1.00K | |||
| Hospitality Property Fund Ltd | 1,394 | 1,401 | 1,391 | 0 | 0.00% | 0 | |||
| JSE | 8,739 | 8,975 | 8,633 | -96 | -1.09% | 133.03K | |||
| Clicks | 29,530 | 29,592 | 28,915 | +16 | +0.05% | 704.82K | |||
| Momentum | 2,046 | 2,115 | 2,000 | +35 | +1.74% | 4.32M | |||
| Drdgold | 1,771 | 1,811 | 1,727 | +10 | +0.57% | 593.54K |
|
|
|
Name
|
Last
|
High
|
Low
|
Chg
|
Chg%
|
Volume
|
Time
|
|---|---|---|---|---|---|---|---|---|---|
| Sibanye Gold ADR | 4.64 | 4.65 | 4.47 | +0.18 | +4.04% | 3.91M | |||
| Gold Fields ADR | 15.540 | 15.660 | 15.250 | +0.250 | +1.63% | 2.12M | |||
| Harmony Gold Mining | 6.295 | 6.318 | 6.180 | +0.055 | +0.88% | 2.81M | |||
| Sasol ADR | 11.28 | 11.27 | 10.99 | +0.24 | +2.22% | 421.71K | |||
| Impala Platinum Holdings Ltd PK | 4.090 | 4.090 | 4.000 | -0.024 | -0.58% | 77.61K |
|
|
|
Name
|
Last
|
High
|
Low
|
Chg
|
Chg%
|
Volume
|
Time
|
|---|---|---|---|---|---|---|---|---|---|
| Freightcar | 2.425 | 2.430 | 2.340 | +0.085 | +3.62% | 9.44K | |||
| Amphenol | 92.11 | 92.32 | 91.14 | +1.12 | +1.23% | 1.73M | |||
| Neuberger Berman RE | 3.020 | 3.025 | 2.935 | +0.080 | +2.72% | 117.49K | |||
| Iovance Biotherapeutics | 6.18 | 6.20 | 5.76 | +0.11 | +1.81% | 2.61M | |||
| Arena Pharma | 99.99 | 100.00 | 99.97 | +0.00 | +0.00% | 0 |
Equities News & Analysis
-
-
Federal Reserve urges banks to routinely utilize discount window for stability
In response to recent banking sector turmoil, Federal Reserve Vice Chair Michael Barr has emphasized the importance of incorporating the Federal Reserve's discount window into banks'...
-
Spotify risk/reward no longer compelling, Citi sees reasons to be 'a tad more cautious'
Spotify (NYSE:SPOT) was downgraded to Neutral from buy at Citi in a note Friday, with analysts maintaining a $190 per share price target on the stock.Analysts told investors that while they...
-
Tesla falls on long wait for Cybertruck payoff, hefty price tag
By Samrhitha A and Chavi Mehta (Reuters) -Tesla shares fell about 2% on Friday after the highly anticipated launch of its Cybertruck left analysts concerned about the electric vehicle's...
-
Nio Inc. reports deliveries of just under 16k units in November
China’s NIO Inc. (NIO), a prominent player in the high-end smart electric vehicle sector, released its November 2023 delivery figures on Friday.In November 2023, NIO achieved a delivery...
-
Dell, Marvell Slide Post Earnings: What Comes Next for the Tech Stocks?
Several tech companies, including {{erl-6520||Marvell (NASDAQ:MRVL) Technology and {{erl-257||Dell Technologies (NYSE:DELL), were seen trading lower in early Friday trade amid...
-
Earnings call: Zhihu Inc. reports Q3 2023 results, announces approval of Zhihaitu AI
Zhihu Inc., the Chinese question-and-answer website, has reported a 12.1% year-on-year increase in total revenue for Q3 2023, driven by robust growth in membership and vocational training...
-
XPeng delivers more than 20k EVs in November
Electric automaker, XPeng (NYSE:XPEV) announced Friday that the Chinese car company had delivered 20,041 Smart EVs in November, representing a 245% increase over the same time last year.The...
-
Novo Nordisk outsized growth 'likely to continue to exceed Street expectations' - Cantor Fitzgerald
Analysts at Cantor Fitzgerald initiated Novo Nordisk (NYSE:NVO) with an Overweight rating and a $120 per share price target in a note Friday.The analysts told investors that "the party is...
-
Pfizer shares slip after drugmaker announces obesity pill setback
Investing.com -- Shares in Pfizer (NYSE:PFE) slumped in early trading on Friday after the drugmaker said that the twice-daily form of its new oral obesity treatment will not advance into...
